{"transactions":[{"id":707189,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T21:00:03.000Z","date":"2026-03-31","kind":"other","planned":false,"acquired":true,"shares":0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"date","element":"transactionDate","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported grant was made in error and has been cancelled."}],"balance_after":0,"derivative":{"underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001683168-26-005620","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316826005620/ownership.xml","form_type":"4/A","original_submission_date":"2026-04-02"}},{"id":820569,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T22:17:06.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":119170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Schechter."}],"balance_after":119170,"derivative":{"exercise_price":0.67,"expiration_date":"2036-03-30","underlying":"Common Stock","underlying_shares":119170},"source":{"system":"sec-edgar","filing":"0001683168-26-002631","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316826002631/ownership.xml","form_type":"4"}},{"id":944962,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-07T22:43:16.000Z","date":"2026-01-07","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":0.8436,"value":16872.0,"ownership":{"direct":true},"balance_after":192500,"source":{"system":"sec-edgar","filing":"0001683168-26-000147","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316826000147/ownership.xml","form_type":"4"}},{"id":944961,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-07T22:43:16.000Z","date":"2026-01-06","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":0.7904,"value":15808.0,"ownership":{"direct":true},"balance_after":172500,"source":{"system":"sec-edgar","filing":"0001683168-26-000147","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316826000147/ownership.xml","form_type":"4"}},{"id":944960,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-07T22:43:16.000Z","date":"2026-01-05","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":0.7776,"value":15552.0,"ownership":{"direct":true},"balance_after":152500,"source":{"system":"sec-edgar","filing":"0001683168-26-000147","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316826000147/ownership.xml","form_type":"4"}},{"id":971647,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-12T22:07:16.000Z","date":"2025-04-25","kind":"grant","planned":false,"acquired":true,"shares":63233,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Schechter. This transaction is late due to an inadvertent administrative error and not any error of Mr. Schechter."}],"balance_after":63233,"derivative":{"exercise_price":1.22,"expiration_date":"2035-04-24","underlying":"Common Stock","underlying_shares":63233},"source":{"system":"sec-edgar","filing":"0001683168-25-009113","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825009113/ownership.xml","form_type":"4"}},{"id":971646,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-12T22:07:16.000Z","date":"2025-12-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":67500,"price":1.02,"value":68850.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction."}],"balance_after":132500,"source":{"system":"sec-edgar","filing":"0001683168-25-009113","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825009113/ownership.xml","form_type":"4"}},{"id":971645,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-12T22:07:16.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":200000,"source":{"system":"sec-edgar","filing":"0001683168-25-009113","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825009113/ownership.xml","form_type":"4"}},{"id":998454,"issuer":{"id":8246,"kind":"organization","name":"TaoWeave, Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true}}],"security":"COMMON STOCK","published_at":"2025-11-17T18:11:43.000Z","date":"2025-11-14","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.91,"value":19100.0,"ownership":{"direct":true},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001437749-25-035345","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/746210/000143774925035345/rdgdoc.xml","form_type":"4"}},{"id":1016360,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-10-17T21:11:11.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by a committee of TAO Synergies Inc.'s (the \"Issuer\") board of directors on July 14, 2025 subject to shareholder approval of an amendment to the Issuer's 2020 Equity Incentive Plan (the \"Plan\") to increase the number of shares authorized for issuance of awards under the Plan. The Issuer received shareholder approval of the amendment to the Plan on August 6, 2025."}],"balance_after":10000,"derivative":{"exercise_price":10.38,"exercise_date":"2026-07-14","expiration_date":"2035-07-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-25-100460","document":"tm2529010-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465925100460/tm2529010-3_4seq1.xml","form_type":"4"}},{"id":1038763,"issuer":{"id":8246,"kind":"organization","name":"TaoWeave, Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true}}],"security":"COMMON STOCK","published_at":"2025-09-17T20:01:33.000Z","date":"2025-09-17","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":2.6951,"value":13475.5,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001437749-25-029280","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/746210/000143774925029280/rdgdoc.xml","form_type":"4"}},{"id":1039939,"issuer":{"id":8246,"kind":"organization","name":"TaoWeave, Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true}}],"security":"COMMON STOCK","published_at":"2025-09-16T19:59:19.000Z","date":"2025-09-16","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":2.7321,"value":27321.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001437749-25-029161","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/746210/000143774925029161/rdgdoc.xml","form_type":"4"}},{"id":1094324,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-07-02T20:05:52.000Z","date":"2025-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":8630,"price":7.85,"value":67745.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction."}],"balance_after":14035,"source":{"system":"sec-edgar","filing":"0001104659-25-065278","document":"tm2519649-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465925065278/tm2519649-3_4seq1.xml","form_type":"4"}},{"id":1094323,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-07-02T20:05:52.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":21575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 21,575 restricted stock units granted on June 30, 2025, under the Issuer's 2020 Equity Incentive Plan which vested immediately upon issuance and (ii) 1,090 shares of common stock."}],"balance_after":22665,"source":{"system":"sec-edgar","filing":"0001104659-25-065278","document":"tm2519649-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465925065278/tm2519649-3_4seq1.xml","form_type":"4"}},{"id":1176366,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-07T21:00:58.000Z","date":"2025-04-03","kind":"grant","planned":false,"acquired":true,"shares":800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following April 3, 2025."}],"balance_after":800,"derivative":{"exercise_price":2.28,"expiration_date":"2035-04-03","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":800},"source":{"system":"sec-edgar","filing":"0001104659-25-032682","document":"tm2511539-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465925032682/tm2511539-2_4seq1.xml","form_type":"4"}},{"id":1452869,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-17T20:58:49.000Z","date":"2024-04-30","kind":"grant","planned":false,"acquired":true,"shares":38009,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Schechter. This transaction is late due to an inadvertent administrative error and not any error of Mr. Schechter."}],"balance_after":38009,"derivative":{"exercise_price":2.12,"expiration_date":"2034-04-30","underlying":"Common Stock","underlying_shares":38009},"source":{"system":"sec-edgar","filing":"0001683168-24-004916","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316824004916/ownership.xml","form_type":"4"}},{"id":1543597,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-10T20:06:20.000Z","date":"2024-04-08","kind":"grant","planned":false,"acquired":true,"shares":800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following April 8, 2024."}],"balance_after":800,"derivative":{"exercise_price":5.39,"expiration_date":"2034-04-08","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":800},"source":{"system":"sec-edgar","filing":"0001104659-24-045799","document":"tm2411531-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465924045799/tm2411531-2_4seq1.xml","form_type":"4"}},{"id":1731597,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-22T22:01:06.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":61248,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":61248,"derivative":{"exercise_price":2.18,"exercise_date":"2023-11-20","expiration_date":"2033-11-20","underlying":"Common Stock","underlying_shares":61248},"source":{"system":"sec-edgar","filing":"0001683168-23-008430","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316823008430/ownership.xml","form_type":"4"}},{"id":1933761,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-31T20:18:39.000Z","date":"2023-03-29","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following March 29, 2023."}],"balance_after":20000,"derivative":{"exercise_price":0.87,"expiration_date":"2033-03-29","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-23-040203","document":"tm2311075-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465923040203/tm2311075-4_4seq1.xml","form_type":"4"}},{"id":2079450,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2022-12-21T01:01:35.000Z","date":"2022-12-16","kind":"sale","acquired":false,"shares":20250,"price":1.1719,"value":23730.975,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold pursuant to a Rule 10b5-1 sales plan, entered into on December 6, 2021 and amended and restated on October 24, 2022, to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":28500,"source":{"system":"sec-edgar","filing":"0001104659-22-128769","document":"tm2233089-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465922128769/tm2233089-4_4seq1.xml","form_type":"4"}},{"id":2111572,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-17T21:01:24.000Z","date":"2022-11-15","kind":"grant","acquired":true,"shares":72000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vested 50% on November 15, 2022 (the \"Issuance Date\") and shall vest 50% on the six-month anniversary of the Issuance Date. The options shall be exercisable for a period of ten years from the date of the grant, irrespective of whether or not the reporting person continues to provide services to the Issuer."}],"balance_after":72000,"derivative":{"exercise_price":6.07,"expiration_date":"2032-11-15","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":72000},"source":{"system":"sec-edgar","filing":"0001104659-22-119873","document":"tm2230820-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465922119873/tm2230820-1_4seq1.xml","form_type":"4"}},{"id":2222718,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-23T22:00:35.000Z","date":"2022-04-05","kind":"other","acquired":true,"shares":0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This filing is deemed to amend the Form 4, which was filed on April 6, 2022, on behalf of Mr. Schechter, showing a grant of 1,500 stock options to purchase shares of common stock of Synaptogenix, Inc. on April 5, 2022, to reflect that such grant was null and void ab initio."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This filing is deemed to amend the Form 4, which was filed on April 6, 2022, on behalf of Mr. Schechter, showing a grant of 1,500 stock options to purchase shares of common stock of Synaptogenix, Inc. on April 5, 2022, to reflect that such grant was null and void ab initio."},{"field":"date","element":"transactionDate","label":"F1","text":"This filing is deemed to amend the Form 4, which was filed on April 6, 2022, on behalf of Mr. Schechter, showing a grant of 1,500 stock options to purchase shares of common stock of Synaptogenix, Inc. on April 5, 2022, to reflect that such grant was null and void ab initio."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This filing is deemed to amend the Form 4, which was filed on April 6, 2022, on behalf of Mr. Schechter, showing a grant of 1,500 stock options to purchase shares of common stock of Synaptogenix, Inc. on April 5, 2022, to reflect that such grant was null and void ab initio."},{"field":"shares","element":"transactionShares","label":"F1","text":"This filing is deemed to amend the Form 4, which was filed on April 6, 2022, on behalf of Mr. Schechter, showing a grant of 1,500 stock options to purchase shares of common stock of Synaptogenix, Inc. on April 5, 2022, to reflect that such grant was null and void ab initio."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This filing is deemed to amend the Form 4, which was filed on April 6, 2022, on behalf of Mr. Schechter, showing a grant of 1,500 stock options to purchase shares of common stock of Synaptogenix, Inc. on April 5, 2022, to reflect that such grant was null and void ab initio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This filing is deemed to amend the Form 4, which was filed on April 6, 2022, on behalf of Mr. Schechter, showing a grant of 1,500 stock options to purchase shares of common stock of Synaptogenix, Inc. on April 5, 2022, to reflect that such grant was null and void ab initio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This filing is deemed to amend the Form 4, which was filed on April 6, 2022, on behalf of Mr. Schechter, showing a grant of 1,500 stock options to purchase shares of common stock of Synaptogenix, Inc. on April 5, 2022, to reflect that such grant was null and void ab initio."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"This filing is deemed to amend the Form 4, which was filed on April 6, 2022, on behalf of Mr. Schechter, showing a grant of 1,500 stock options to purchase shares of common stock of Synaptogenix, Inc. on April 5, 2022, to reflect that such grant was null and void ab initio."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This filing is deemed to amend the Form 4, which was filed on April 6, 2022, on behalf of Mr. Schechter, showing a grant of 1,500 stock options to purchase shares of common stock of Synaptogenix, Inc. on April 5, 2022, to reflect that such grant was null and void ab initio."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This filing is deemed to amend the Form 4, which was filed on April 6, 2022, on behalf of Mr. Schechter, showing a grant of 1,500 stock options to purchase shares of common stock of Synaptogenix, Inc. on April 5, 2022, to reflect that such grant was null and void ab initio."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"This filing is deemed to amend the Form 4, which was filed on April 6, 2022, on behalf of Mr. Schechter, showing a grant of 1,500 stock options to purchase shares of common stock of Synaptogenix, Inc. on April 5, 2022, to reflect that such grant was null and void ab initio."}],"balance_after":0,"derivative":{"underlying":"Common Stock, par value $0.0001 per share"},"source":{"system":"sec-edgar","filing":"0001104659-22-073971","document":"tm2219110-2_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465922073971/tm2219110-2_4aseq1.xml","form_type":"4/A","original_submission_date":"2022-04-06"}},{"id":2302214,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-06T21:01:00.000Z","date":"2022-04-05","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following April 5, 2022."}],"balance_after":1500,"derivative":{"exercise_price":7.41,"expiration_date":"2032-04-05","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001104659-22-043273","document":"tm2212026-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465922043273/tm2212026-2_4seq1.xml","form_type":"4"}},{"id":2632996,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-07-15T22:07:19.000Z","date":"2021-07-13","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 45,000 restricted stock units granted on July 13, 2021 (the \"Grant Date\") under the Issuer's 2020 Equity Incentive Plan which will vest 50% on the six month anniversary of the Grant Date and the remaining 50% on the one year anniversary of the Grant Date."}],"balance_after":48750,"source":{"system":"sec-edgar","filing":"0001104659-21-092718","document":"tm2122331-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1571934/000110465921092718/tm2122331-5_4seq1.xml","form_type":"4"}},{"id":2957757,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:39:51.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":80000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":0.972,"underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001104659-20-132148","document":"tm2037705d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920132148/tm2037705d1_4.xml","form_type":"4"}},{"id":2957756,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:39:51.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":0.8203,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-20-132148","document":"tm2037705d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920132148/tm2037705d1_4.xml","form_type":"4"}},{"id":2957755,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:39:51.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":4.06,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-20-132148","document":"tm2037705d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920132148/tm2037705d1_4.xml","form_type":"4"}},{"id":2957754,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:39:51.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":3.93,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-20-132148","document":"tm2037705d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920132148/tm2037705d1_4.xml","form_type":"4"}},{"id":2957753,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:39:51.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":1562,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":4.44,"underlying":"Common Stock","underlying_shares":1562},"source":{"system":"sec-edgar","filing":"0001104659-20-132148","document":"tm2037705d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920132148/tm2037705d1_4.xml","form_type":"4"}},{"id":2957752,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:39:51.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":7813,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":4.44,"underlying":"Common Stock","underlying_shares":7813},"source":{"system":"sec-edgar","filing":"0001104659-20-132148","document":"tm2037705d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920132148/tm2037705d1_4.xml","form_type":"4"}},{"id":2957751,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-03T21:39:51.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the  common stock was disposed of as follows: the reporting person received one (1) share of Petros Common Stock for every five (5) shares of Neurotrope common stock held."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-20-132148","document":"tm2037705d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920132148/tm2037705d1_4.xml","form_type":"4"}},{"id":2965077,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-27T17:06:50.000Z","date":"2020-11-24","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will immediately vest and become exercisable subject to and upon consummation of (1) the merger of PM Merger Sub 1, LLC with and into Metuchen Pharmaceuticals, LLC (\"Metuchen\"), with Metuchen surviving as a wholly-owned subsidiary of Petros Pharmaceuticals, Inc. (\"Petros\") and (2) the merger of PN Merger Sub 2, Inc. with and into Neurotrope, Inc. (\"Neurotrope\"), with Neurotrope surviving as a wholly-owned subsidiary of Petros (together, the \"Mergers\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"In the event the reporting person departs from the board of directors following the consummation of the Mergers, the options shall expire on the date that is one year from the date of the consummation of the Mergers."}],"balance_after":80000,"derivative":{"exercise_price":0.972,"expiration_date":"2030-11-24","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001104659-20-130069","document":"tm2037145d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920130069/tm2037145d1_4.xml","form_type":"4"}},{"id":2996273,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-02T09:01:00.000Z","date":"2020-10-30","kind":"purchase","acquired":true,"shares":25000,"price":0.9777,"value":24442.5,"ownership":{"direct":true},"balance_after":75000,"source":{"system":"sec-edgar","filing":"0001104659-20-120279","document":"tm2034740d1_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920120279/tm2034740d1_form4.xml","form_type":"4"}},{"id":2999913,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-26T09:00:28.000Z","date":"2020-10-22","kind":"purchase","acquired":true,"shares":25000,"price":1.1,"value":27500.0,"ownership":{"direct":true},"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001104659-20-118010","document":"tm2034177d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920118010/tm2034177d1_4.xml","form_type":"4"}},{"id":3001316,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-22T09:00:47.000Z","date":"2020-10-21","kind":"purchase","acquired":true,"shares":22988,"price":1.1,"value":25286.8,"ownership":{"direct":true},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001104659-20-117012","document":"tm2034030d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920117012/tm2034030d1_4.xml","form_type":"4"}},{"id":3001315,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-22T09:00:47.000Z","date":"2020-10-20","kind":"purchase","acquired":true,"shares":2012,"price":1.1,"value":2213.2,"ownership":{"direct":true},"balance_after":2012,"source":{"system":"sec-edgar","filing":"0001104659-20-117012","document":"tm2034030d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920117012/tm2034030d1_4.xml","form_type":"4"}},{"id":3195890,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-03-24T18:01:55.000Z","date":"2020-03-20","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock option award was made in connection with the Issuer's annual equity grants to non-employee directors pursuant to the terms of the Neurotrope, Inc. 2017 Equity Incentive Plan."}],"balance_after":10000,"derivative":{"exercise_price":0.8203,"exercise_date":"2021-03-20","expiration_date":"2030-03-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-20-037866","document":"tm2013506d4_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920037866/tm2013506d4_4.xml","form_type":"4"}},{"id":3555663,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-04-15T17:00:51.000Z","date":"2019-03-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock option award was made in connection with the Issuer's annual equity grants to non-employee directors pursuant to the terms of the Neurotrope, Inc. 2017 Equity Incentive Plan."}],"balance_after":10000,"derivative":{"exercise_price":4.06,"exercise_date":"2020-03-15","expiration_date":"2029-03-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001144204-19-019711","document":"tv518874_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000114420419019711/tv518874_form4.xml","form_type":"4"}},{"id":3687792,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-01-24T18:04:17.000Z","date":"2019-01-22","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award was made pursuant to the terms of the Neurotrope, Inc. 2017 Equity Incentive Plan. The stock options shall vest according to the following schedule: 50% vest on the date of grant, with the remaining stock options vesting in equal quarterly installments over a two-year period following the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":3.93,"expiration_date":"2029-01-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001144204-19-002690","document":"tv511531_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000114420419002690/tv511531_4.xml","form_type":"4"}},{"id":3728827,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-12-17T17:00:41.000Z","date":"2018-12-13","kind":"grant","acquired":true,"shares":1562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These securities were issued in connection with the Reporting Person's service on the Audit Committee of the Issuer's board of directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options shall vest in equal daily installments over a three-year period beginning on the date of grant."}],"balance_after":1562,"derivative":{"exercise_price":4.44,"expiration_date":"2028-12-13","underlying":"Common Stock","underlying_shares":1562},"source":{"system":"sec-edgar","filing":"0001144204-18-064946","document":"tv509204_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000114420418064946/tv509204_4.xml","form_type":"4"}},{"id":3728826,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":29829,"kind":"person","name":"SCHECHTER JONATHAN","position":1,"cik":"0001619259","reported_name":"SCHECHTER JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-12-17T17:00:41.000Z","date":"2018-12-13","kind":"grant","acquired":true,"shares":7813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities were issued in connection with the Reporting Person's appointment as a non-employee director to the Issuer's board of directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options shall vest in equal daily installments over a three-year period beginning on the date of grant."}],"balance_after":7813,"derivative":{"exercise_price":4.44,"expiration_date":"2028-12-13","underlying":"Common Stock","underlying_shares":7813},"source":{"system":"sec-edgar","filing":"0001144204-18-064946","document":"tv509204_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000114420418064946/tv509204_4.xml","form_type":"4"}}]}